First Header Logo Second Header Logo

Agshin F. Taghiyev PhD, FACMG

TitleAssistant Professor
InstitutionWake Forest School of Medicine
DepartmentPathology
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Umesalma S, Kaemmer CA, Kohlmeyer JL, Letney BL, Schab AM, Reilly JA, Sheehy RM, Hagen J, Tiwari N, Zhan F, Leidinger MR, O'Dorisio TM, Dillon JS, Merrill RA, Meyerholz DK, Perl AL, Brown BJ, Braun TA, Scott AT, Ginader T, Taghiyev AF, Zamba GK, Howe JR, Strack S, Bellizzi AM, Narla G, Darbro BW, Quelle FW, Quelle DE. RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growth. J Clin Invest. 2019 Feb 05. PMID: 30721156.
      Citations:    
    2. Hagen J, Muniz VP, Falls KC, Reed SM, Taghiyev AF, Quelle FW, Gourronc FA, Klingelhutz AJ, Major HJ, Askeland RW, Sherman SK, O'Dorisio TM, Bellizzi AM, Howe JR, Darbro BW, Quelle DE. RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent manner. Cancer Res. 2014 Nov 15; 74(22):6661-70. PMID: 25273089.
      Citations:    
    3. Sieren JC, Meyerholz DK, Wang XJ, Davis BT, Newell JD, Hammond E, Rohret JA, Rohret FA, Struzynski JT, Goeken JA, Naumann PW, Leidinger MR, Taghiyev A, Van Rheeden R, Hagen J, Darbro BW, Quelle DE, Rogers CS. Development and translational imaging of a TP53 porcine tumorigenesis model. J Clin Invest. 2014 Sep; 124(9):4052-66. PMID: 25105366.
      Citations:    
    4. Taghiyev AF, Rokhlin OW, Glover RB. Caspase-2-Based Regulation of the Androgen Receptor and Cell Cycle in the Prostate Cancer Cell Line LNCaP. Genes Cancer. 2011 Jul; 2(7):745-52. PMID: 22207900.
      Citations:    
    5. Rokhlin OW, Guseva NV, Taghiyev AF, Glover RA, Cohen MB. KN-93 inhibits androgen receptor activity and induces cell death irrespective of p53 and Akt status in prostate cancer. Cancer Biol Ther. 2010 Feb; 9(3):224-35. PMID: 20023417.
      Citations:    
    6. Du J, Martin SM, Levine M, Wagner BA, Buettner GR, Wang SH, Taghiyev AF, Du C, Knudson CM, Cullen JJ. Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer. Clin Cancer Res. 2010 Jan 15; 16(2):509-20. PMID: 20068072.
      Citations:    
    7. Rokhlin OW, Scheinker VS, Taghiyev AF, Bumcrot D, Glover RA, Cohen MB. MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer. Cancer Biol Ther. 2008 Aug; 7(8):1288-96. PMID: 18497571.
      Citations:    
    8. Guseva NV, Rokhlin OW, Taghiyev AF, Cohen MB. Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L). Breast Cancer Res Treat. 2008 Feb; 107(3):349-57. PMID: 17453339.
      Citations:    
    9. Rokhlin OW, Taghiyev AF, Bayer KU, Bumcrot D, Koteliansk VE, Glover RA, Cohen MB. Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survival. Cancer Biol Ther. 2007 May; 6(5):732-42. PMID: 17387273.
      Citations:    
    10. Taghiyev AF, Guseva NV, Glover RA, Rokhlin OW, Cohen MB. TSA-induced cell death in prostate cancer cell lines is caspase-2 dependent and involves the PIDDosome. Cancer Biol Ther. 2006 Sep; 5(9):1199-205. PMID: 17110788.
      Citations:    
    11. Rokhlin OW, Glover RB, Guseva NV, Taghiyev AF, Kohlgraf KG, Cohen MB. Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells. Mol Cancer Res. 2006 Feb; 4(2):113-23. PMID: 16513842.
      Citations:    
    12. Rokhlin OW, Taghiyev AF, Guseva NV, Glover RA, Chumakov PM, Kravchenko JE, Cohen MB. Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP. Oncogene. 2005 Oct 13; 24(45):6773-84. PMID: 16007156.
      Citations:    
    13. Taghiyev AF, Guseva NV, Sturm MT, Rokhlin OW, Cohen MB. Trichostatin A (TSA) sensitizes the human prostatic cancer cell line DU145 to death receptor ligands treatment. Cancer Biol Ther. 2005 Apr; 4(4):382-90. PMID: 15846101.
      Citations:    
    14. Guseva NV, Taghiyev AF, Sturm MT, Rokhlin OW, Cohen MB. Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell lines. Mol Cancer Res. 2004 Oct; 2(10):574-84. PMID: 15498932.
      Citations:    
    15. Rokhlin OW, Guseva NV, Taghiyev AF, Glover RA, Cohen MB. Multiple effects of N-alpha-tosyl-L-phenylalanyl chloromethyl ketone (TPCK) on apoptotic pathways in human prostatic carcinoma cell lines. Cancer Biol Ther. 2004 Aug; 3(8):761-8. PMID: 15197350.
      Citations:    
    16. Guseva NV, Taghiyev AF, Rokhlin OW, Cohen MB. Death receptor-induced cell death in prostate cancer. J Cell Biochem. 2004 Jan 01; 91(1):70-99. PMID: 14689583.
      Citations:    
    17. Taghiyev AF, Guseva NV, Harada H, Knudson CM, Rokhlin OW, Cohen MB. Overexpression of BAD potentiates sensitivity to tumor necrosis factor-related apoptosis-inducing ligand treatment in the prostatic carcinoma cell line LNCaP. Mol Cancer Res. 2003 May; 1(7):500-7. PMID: 12754297.
      Citations:    
    18. Ermakov OA, Surin VL, Titov SV, Tagiev AF, Luk'ianenko AV, Formozov NA. [Study of hybridization in four species of ground squirrels (spermophilus: Rodentia, Sciuridae) by molecular genetic methods]. Genetika. 2002 Jul; 38(7):950-64. PMID: 12174588.
      Citations:    
    19. Rokhlin OW, Glover RA, Taghiyev AF, Guseva NV, Seftor RE, Shyshynova I, Gudkov AV, Cohen MB. Bisindolylmaleimide IX facilitates tumor necrosis factor receptor family-mediated cell death and acts as an inhibitor of transcription. J Biol Chem. 2002 Sep 06; 277(36):33213-9. PMID: 12091392.
      Citations:    
    20. Guseva NV, Taghiyev AF, Rokhlin OW, Cohen MB. Contribution of death receptor and mitochondrial pathways to Fas-mediated apoptosis in the prostatic carcinoma cell line PC3. Prostate. 2002 Jun 01; 51(4):231-40. PMID: 11987151.
      Citations:    
    21. Rokhlin OW, Guseva NV, Tagiyev AF, Glover RA, Cohen MB. Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP. Prostate. 2002 Jun 01; 52(1):1-11. PMID: 11992615.
      Citations:    
    22. Rokhlin OW, Taghiyev AF, Guseva NV, Glover RA, Syrbu SI, Cohen MB. TRAIL-DISC formation is androgen-dependent in the human prostatic carcinoma cell line LNCaP. Cancer Biol Ther. 2002; 1(6):631-7. PMID: 12642685.
      Citations:    
    23. Rokhlin OW, Guseva N, Tagiyev A, Knudson CM, Cohen MB. Bcl-2 oncoprotein protects the human prostatic carcinoma cell line PC3 from TRAIL-mediated apoptosis. Oncogene. 2001 May 17; 20(22):2836-43. PMID: 11420695.
      Citations:    
    24. Misiurin AV, Surin VL, Tagiev AF. [New breakpoints of t(9;22) translocation in chronic myeloid leukemia]. Bioorg Khim. 1999 Mar; 25(3):234-6. PMID: 10382043.
      Citations:    
    25. Turkina AG, Logacheva NP, Stromskaya TP, Zabotina TN, Kuznetzov SV, Sachibzadaeva KK, Tagiev A, Juravlev VS, Khoroshko ND, Baryshnikov AY, Stavrovskaya AA. Studies of some mechanisms of drug resistance in chronic myeloid leukemia (CML). Adv Exp Med Biol. 1999; 457:477-88. PMID: 10500825.
      Citations:    
    26. Khoroshko ND, Mokeeva RA, Turkina AG, Arkhipova NV, Semenova EA, Zakharova AV, Kobzev IuN, Sakhibzadaeva KK, Tagiev AF. [The hypereosinophilic variant of Ph'-positive chronic myeloleukemia]. Ter Arkh. 1998; 70(7):29-37. PMID: 9742632.
      Citations:    
    27. Surin VL, Bannikova AA, Tagiev AF, Osokina AV, Formozov NA. [Molecular systematic of hedgehogs (Erinaceidae, Insectivora) of the northeastern palearctic: testing the new method]. Dokl Akad Nauk. 1997 Mar; 353(2):278-80. PMID: 9244493.
      Citations:    
    28. Kurabekova RM, Borovkova TV, Misiurina OIu, Sats NV, Tagiev AF, Zborovskii SS, Grineva NI. [Transcripts of integrated simian adenovirus SA7 oncogenes in SH2 rat fibroblasts, transformed by adenovirus SA7 DNA]. Mol Biol (Mosk). 1996; 30(4):808-17. PMID: 8965815.
      Citations:    
    29. Tagiev AF, Surin VL, Osokina AV, Luk'ianenko AV, Smirnova OV, Tsetaeva NV, Mikhailova EA, Isaev VG, Grineva NI. [Polymorphism at codon 117 of the granulocyte-macrophage colony-stimulating factor (GM-CSF) gene]. Genetika. 1995 Oct; 31(10):1370-4. PMID: 8543141.
      Citations:    
    30. Surin VL, Luk'ianenko AV, Tagiev AF, Smirnova OV, Plutalov OV, Berlin IuA. [New polymorphic variants of the gene for human blood coagulation factor IX]. Genetika. 1995 Apr; 31(4):528-31. PMID: 7607439.
      Citations:    
    31. Surin VL, Luk'ianenko AV, Tagiev AF, Smirnova OV. [A new polymorphism in the human factor IX gene, useful for determining carriers of hemophilia B]. Genetika. 1994 Jun; 30(6):740-2. PMID: 7958786.
      Citations:    
    32. Tagiev AF, Surin VL, Luk'ianenko AV, Kulieva EA, Mamedova TA, Solov'ev GIa. [Spectrum of DNA haplotypes and beta-thalassemia mutations linked with them in the Azerbaijan Republic]. Genetika. 1994 Apr; 30(4):535-8. PMID: 8045401.
      Citations:    
    33. Surin VL, Sats NV, Tagiev AF. [Structure of integrated oncogens E1A and E1B in a malignant line of rat SH2 fibroblasts, transformed by monkey adenovirus SA7 (C8) DNA]. Mol Biol (Mosk). 1994; 28(2):350-4. PMID: 8183267.
      Citations:    
    34. Sats NV, Surin VL, Tagiev AF. [Nucleotide sequence of the E1B area and the adjacent 3'-terminal segment of the E1A oncogene from monkey adenovirus SA7 (C8)]. Mol Biol (Mosk). 1994; 28(2):342-9. PMID: 8183266.
      Citations:    
    35. Surin VL, Tagiev AF, Solov'ev GIa, Luk'ianenko AV, Plutalov OV, Berlin IuA. [Use of the polymerase chain reaction to detect beta-thalassemia mutations in heterozygous carriers from Azerbaijan while performing prenatal DNA-diagnosis]. Genetika. 1993 May; 29(5):820-4. PMID: 8335239.
      Citations:    
    36. Luk'ianenko AV, Surin VL, Voskoboeva EIu, Tagiev AF, Krutov AA, Solov'ev GIa. [A PCR-system of analyzing polymorphic markers in gamma-A and gamma-G globin genes and gene for human blood coagulation factor IX with an internal control of the completeness of restriction hydrolysis]. Genetika. 1993 Mar; 29(3):388-92. PMID: 8098004.
      Citations:    
    37. Pokrovskaia ES, Domninskii DA, Babushkina EA, Krutov AA, Tagiev AF, Grineva NI. [Cloning the region of chromosome 22 participating in translocation t(9,22) in human chronic myeloid leukemia]. Mol Biol (Mosk). 1993; 27(1):185-91. PMID: 8483470.
      Citations:    
    38. Tagiev AF, Surin VL, Gol'tsov AA, Lukianenko AV, et al. The spectrum of beta-thalassemia mutations in Azerbaijan. Hum Mutat. 1993; 2(2):152-4. PMID: 8318994.
      Citations:    
    39. Kolesnikova TN, Moliaka IuK, Surin VL, Luk'ianenko AV, Asanov AIu, Tagiev AF, Solov'ev GIa. [A case of prenatal diagnosis of beta-thalassemia by polymerase chain reaction]. Genetika. 1992 Dec; 28(12):130-4. PMID: 1363470.
      Citations:    
    40. Kolesnikova TN, Surin VL, Moliaka IuK, Luk'ianenko AV, Tagiev AF, Asanov AIu, Bobokhodzhaev ZM, Solov'ev GIa. [Molecular nature of beta-thalassemia in Tajikistan: a four base pair deletion in codons 41-42 of the beta-globin gene]. Genetika. 1992 Nov; 28(11):28-33. PMID: 1286798.
      Citations:    
    41. Khrennikov VIu, Deev AI, Sitnikov VF, Tagiev AF. [Increase of the negative charge of erythrocyte membrane proteins in hereditary neuromuscular diseases]. Biull Eksp Biol Med. 1990 Oct; 110(10):427-8. PMID: 2279101.
      Citations:    
    42. Solov'ev GIa, Luk'ianenko AV, Tagiev AF, Dadasheva TS, Rustamov RSh. [DNA diagnosis of beta-thalassemia. Study of restriction fragment length polymorphisms in families with affected children]. Gematol Transfuziol. 1990 Oct; 35(10):3-6. PMID: 1706673.
      Citations:    
    Taghiyev's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (237)
    Explore
    _
    Same Department Expand Description
    Explore
    _